Crossmark

Efficacy, safety and satisfaction of using emicizumab in hemophilia A patients without factor VIII inhibitors: A systematic review

Crossref DOI link: https://doi.org/10.1016/j.htct.2025.103849

Published Print: 2025-07

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Araujo, Isabela de Oliveira https://orcid.org/0000-0001-9794-9957
Suassuna, Lucas Fernandes https://orcid.org/0000-0001-7327-692X
dos Santos, Isabela Lima https://orcid.org/0009-0001-2062-684X
Rodrigues, Daniela de Oliveira Werneck https://orcid.org/0000-0003-3062-2954
License Information

Text and Data Mining valid from 2025-07-01

Text and Data Mining valid from 2025-07-01

Version of Record valid from 2025-05-14
More Information

This article is maintained by: Elsevier

Article Title: Efficacy, safety and satisfaction of using emicizumab in hemophilia A patients without factor VIII inhibitors: A systematic review

Journal Title: Hematology, Transfusion and Cell Therapy

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.htct.2025.103849

Content Type: article

Copyright: © 2025 Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier España, S.L.U.